LLY
Eli Lilly and Company
LLY has the edge over WRBY overall, supported by stronger fundamentals and lower modeled downside.
WRBY
Warby Parker Inc.
WRBY's outlook is improving, though it still trails on the overall score.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
WRBY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Under pressure | |
| Strong |
WRBY's revenue, profitability and balance sheet are currently healthy, but its cash flow is under pressure.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
WRBY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 53x | $26.73 | — |
| Cheap | 439x | $21.93 | -18% |
| Current | 535x | $26.73 | — |
| Fair | 2,274x | $114 | +325% |
| Expensive | 2,646x | $132 | +395% |
Historical ranges are pointers, not guarantees.
WRBY has the edge over LLY in the historical PE scenario, which offers more potential upside but is not a forecast.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
WRBY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for WRBY, with profitability improving. However, they disagree widely on these estimates.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY's earnings per share have climbed steadily: $30.81 over the past year, up 51% from the year before, and higher year over year for 11 quarters in a row.
WRBY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.51 | +916% |
| Q3 2026 | $0.05 | +400% |
| Q2 2026 | $0.06 | +$0.13 |
| Q1 2026 | $0.01 | +$0.13 |
| Q4 2025 | $0.01 | +$0.18 |
| Q3 2025 | $0.01 | +$0.28 |
| Q2 2025 | -$0.07 | +$0.32 |
| Q1 2025 | -$0.12 | +$0.35 |
| Q4 2024 | -$0.17 | +$0.37 |
WRBY's earnings per share have climbed steadily: $0.05 over the past year, about five times what it earned the year before, and higher year over year every quarter since early 2023.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY has the edge over WRBY on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY has the edge over WRBY on profitability, with a higher operating margin.
WRBY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $244.7M | +10% |
| Q2 2026 | $235.5M | +9.8% |
| Q1 2026 | $242.4M | +8.3% |
| Q4 2025 | $212M | +11% |
| Q3 2025 | $221.7M | +15% |
| Q2 2025 | $214.5M | +14% |
| Q1 2025 | $223.8M | +12% |
| Q4 2024 | $190.6M | +18% |
WRBY's revenue has grown year over year every quarter since early 2021: $245M last quarter, up 10% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.4% | -0.2 points |
| Q2 2026 | 1.3% | +3.5 points |
| Q1 2026 | 0.7% | -0.4 points |
| Q4 2025 | -3.2% | +1.7 points |
| Q3 2025 | 1.6% | +5 points |
| Q2 2025 | -2.1% | +2.6 points |
| Q1 2025 | 1.1% | +3.7 points |
| Q4 2024 | -4.9% | +8.4 points |
WRBY's operating margin was 1.4% last quarter, about level with the same quarter a year ago.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over WRBY on cash flow, with more consistent year-over-year improvement.
WRBY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$2M | -$459K |
| Q2 2026 | $6.8M | -72% |
| Q1 2026 | $8.4M | -37% |
| Q4 2025 | $8.1M | +271% |
| Q3 2025 | -$1.5M | -112% |
| Q2 2025 | $23.9M | +71% |
| Q1 2025 | $13.2M | +141% |
| Q4 2024 | $2.2M | +2282% |
WRBY usually generates cash, though not every quarter: the latest was −$2M, but it generated $21M over the past year.
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over WRBY on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
WRBY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +401K shares |
| 1 year | +0.6% | +741K shares |
| 3 years | +6.9% | +8.1M shares |
| 5 years | +101% | +63.3M shares |
WRBY has 126M diluted shares, up 0.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q2 2021 | $2M |
| Q1 2021 | $6.1M |
| Q4 2020 | — |
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
WRBY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -5.1x | Net Cash |
| Q2 2026 | -5.3x | Net Cash |
| Q1 2026 | -6.3x | Net Cash |
| Q4 2025 | -6.4x | Net Cash |
| Q3 2025 | -6.7x | Net Cash |
| Q2 2025 | -9.3x | Net Cash |
| Q1 2025 | -10.6x | Net Cash |
| Q4 2024 | -16.1x | Net Cash |
WRBY has the edge over LLY on leverage, with a lower net debt burden relative to earnings.
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
WRBY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.1 | Neutral |
| Stochastic | 40.8 | Neutral |
WRBY's weekly RSI is 53 (neutral) and its Stochastic is 41 (neutral).
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY has the edge over WRBY on valuation relative to its sector.
WRBY PE vs Healthcare Sector
| Metric | WRBY | Sector median | Relative |
|---|---|---|---|
| PE | 535x | 26x | 1,968% above |
| PE % | 26 | 39 | 13 pts below |
WRBY is trading at 535x earnings, a 1968% premium to the Healthcare sector's median of 26x.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY is in an uptrend: it's above all five of its weekly moving averages, and 79% above its 200-week average.
WRBY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $25.6 | 4.3% above |
| 20 week MA | $25.9 | 3.3% above |
| 50 week MA | $25.2 | 6.2% above |
| 100 week MA | $23.7 | 13% above |
| 200 week MA | $18.9 | 42% above |
WRBY is in an uptrend: it's above all five of its weekly moving averages, and 42% above its 200-week average.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has the edge over WRBY on returns for 2026, with the stronger performance.
WRBY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $53.7 | $47.5 | -12% |
| 2022 | $47.5 | $13.5 | -72% |
| 2023 | $13.5 | $14.1 | +4.2% |
| 2024 | $14.1 | $24.4 | +73% |
| 2025 | $24.4 | $24.2 | -1% |
| 2026 YTD | $24.2 | $26.7 | +11% |
WRBY has finished lower in three of the last five years. It's up 11% so far in 2026.